Loncar Lyon Jenkins is now investigating claims of nerve damage caused by taking Levaquin, Cipro, and other Fluoroquinolone (FLQ) antibiotics.
If you or someone you love are among those who experienced nerve damage as a result of taking Fluoroquinolone (FLQ) antibiotics, you may be eligible for compensation. Loncar Lyon Jenkins is investigating cases in all 50 states. Contact Loncar Lyon Jenkins immediately for a free, confidential case evaluation using the form to the side or by calling toll free at 800.285.4878. Antibiotic nerve damage lawsuits are being evaluated on a contingency fee basis, meaning you pay nothing unless a recovery is obtained. Our staff will obtain all medical records necessary to evaluate your case.
May 25, 2016 Fluoroquinolone Antibacterial Drugs Update:
On May 12, 2016 the FDA announced mandatory labeling changes for fluoroquinolone antibiotics which includes an updated boxed warning stating that the serious side effects associated with fluoroquinolones generally outweigh the benefits for patients with sinusitis, bronchitis and uncomplicated urinary tract infections who have other treatment options. The FDA believes fluoroquinolones should be reserved for those who do not have alternative treatment options.
The FDA safety review showed that fluoroquinolones are associated with disabling and potentially permanent, serious side effects involving the tendons, muscles, joints, nerves and central nervous system. As a result, the FDA is requiring the label changes for all systemic (i.e. tablet, capsule, and injectable) fluoroquinolone antibacterial drugs to reflect this new safety information.
Fluoroquinolones (FLQ) Antibiotics on the Market
Fluoroquinolone (FLQ) antibiotics are a class of synthetic antibiotics that directly inhibit bacterial DNA synthesis. FLQs are generally reserved for treating severe bacterial infections that wouldn’t respond to any other treatment. Unfortunately antibiotics are over prescribed. You may have used FLQ antibiotics for relatively mild infections. Over time several FLQ drugs have been taken off the market, but six remain FDA-approved for use in the United States:
FDA Mandated Label Changes for FLQs
Evidence of an association between FLQ’s and peripheral neuropathy (nerve damage) was first noticed in 1992. Dr. Aoun wrote a letter to The Lancet, a British medical journal, raising concerns over a 37-year old patient who developed peripheral neuropathy after taking FLQs. Papers and studies followed over years and in September 2004 the FDA approved amending the labels of FLQ products to include the possibility of peripheral nerve damage. This new label implied that nerve damage was rare and could be avoided by discontinued use of the product. Over time, evidence began to mount of the relationship between FLQs and severe, long-term peripheral nerve damage. It did not appear to be as rare and avoidable as the manufacturers had warned. In August of 2013, the FDA stated that serious nerve damage potentially caused by FLQs may occur soon after these drugs are taken and may be permanent. They mandated that all approved fluoroquinolone antibacterial drugs update their labels to better describe the serious side effects of peripheral neuropathy.
Symptoms of Peripheral Neuropathy
- Burning in the arms, feet, and legs
- Nerve spasms
- Changes in sensation to light touch, pain or temperature
- Changes in sensation to the body position
Usually, the diagnosis of peripheral neuropathy takes many years and multiple other maladies must be ruled out first. Because of the length of time between use and diagnosis many patients fear they will not qualify for compensation. Do not reach this conclusion without consulting an experienced pharmaceutical attorney.
Do You Have a Fluoroquinolone (FLQ) Antibiotics Lawsuit?
If you are experiencing nerve damage as a result of FLQ antibiotics, you may be eligible for compensation. If you have suffered from motor, sensory, or autonomic nerve damage the law limits your time to act so contact Loncar Lyon Jenkins immediately for a free, confidential case evaluation using the form on the side or by calling toll free at 800.285.4878.